Calculator Template: Difference between revisions

Jump to navigation Jump to search
Gerald Chi (talk | contribs)
Ssharfaei (talk | contribs)
m Protected "Calculator Template" ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))
 
(8 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hatnote|For an example of risk score, see [[IMPROVEDD VTE risk score]]}}
{{CMG}}; {{AE}} (insert your name here)
{{CMG}}; {{AE}} (insert your name here)


Line 9: Line 8:


==[Name of the Score]==
==[Name of the Score]==
===Historical Perspective===
[Name of the Score] was invented by (Author) et al in (year), and has been externally validated in (other populations/subsequent studies).(add references)
[Name of the Score] was invented by (Author) et al in (year), and has been externally validated in (other populations/subsequent studies).(add references)


===Purpose===
[Name of the Score] is a (risk assessment tool/risk stratification scheme) designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).
[Name of the Score] is a (risk assessment tool/risk stratification scheme) designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).


Line 21: Line 17:


[Name of the Score] is a (decision tool) designed to assist the decision-making pertaining to the (risk/benefit) of (antiplatelet/antithrombotic/other treatment) for (acute coronary syndrome/other conditions) among (hospitalized patients/healthy individuals/other population).
[Name of the Score] is a (decision tool) designed to assist the decision-making pertaining to the (risk/benefit) of (antiplatelet/antithrombotic/other treatment) for (acute coronary syndrome/other conditions) among (hospitalized patients/healthy individuals/other population).
===Guideline Recommendations===
[Name of the Score] has been included in the (ACC/AHA/ESC/ACCP) guideline recommendations for the (risk assessment/diagnosis/exclusion) of (acute pulmonary embolism/other disease) among (hospitalized patients/healthy individuals/other population) (class of recommendation: XXX; level of evidence: XXX).


==[Name of the Score] Calculator==
==[Name of the Score] Calculator==
Line 29: Line 22:


(insert widget here)
(insert widget here)
<nowiki>{{#widget:Widget_Name}}</nowiki>


==Interpretation==
==Interpretation==
* Score ≤1: low-risk (<1% mortality); no treatment or hospital admission is required.
* Score ≤ 1: low-risk (&lt; 1% mortality); no treatment or hospital admission is required.
* Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization.
* Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization.
* Score ≥4: high-risk (>5% mortality); treatment/hospitalization is warranted.
* Score ≥ 4: high-risk (&gt; 5% mortality); treatment/hospitalization is warranted.


==See also==
==See also==

Latest revision as of 16:41, 5 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: (insert your name here)

Synonyms and keywords: (add synonyms and create redirects)

Overview

[Name of the Score] is a (± validated) risk assessment tool designed to assess the (30-day/10-year/other timeframe) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).

[Name of the Score]

[Name of the Score] was invented by (Author) et al in (year), and has been externally validated in (other populations/subsequent studies).(add references)

[Name of the Score] is a (risk assessment tool/risk stratification scheme) designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).

[Name of the Score] is a (clinical prediction rule) devised to assess the severity of (acute pancreatitis/other disease) among (hospitalized patients/healthy individuals/other population) in the (outpatient/inpatient/surgical/medical/emergency room) setting.

[Name of the Score] is a (prediction model) developed to estimate the (mortality/bleeding rate/pre-test probability) of (acute pulmonary embolism/other disease) among (hospitalized patients/healthy individuals/other population).

[Name of the Score] is a (decision tool) designed to assist the decision-making pertaining to the (risk/benefit) of (antiplatelet/antithrombotic/other treatment) for (acute coronary syndrome/other conditions) among (hospitalized patients/healthy individuals/other population).

[Name of the Score] Calculator

Shown below is the calculator for [Name of the Score] (check all the boxes that apply):

(insert widget here) {{#widget:Widget_Name}}

Interpretation

  • Score ≤ 1: low-risk (< 1% mortality); no treatment or hospital admission is required.
  • Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization.
  • Score ≥ 4: high-risk (> 5% mortality); treatment/hospitalization is warranted.

See also

  • (Relevant score 1)
  • (Relevant score 2)
  • (Relevant score 3)

References